Published in World J Gastroenterol on December 21, 2010
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Variceal hemorrhage: Saudi tertiary center experience of clinical presentations, complications and mortality. World J Hepatol (2012) 0.89
Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. Hepatology (2013) 0.86
The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis. Dtsch Arztebl Int (2013) 0.85
Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2005) 3.68
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med (1981) 3.13
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med (1992) 2.31
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med (1993) 2.16
Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis (1999) 2.15
Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized, controlled trials. Gastrointest Endosc (2009) 2.10
Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med (2008) 2.05
Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med (1995) 2.04
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology (2005) 1.92
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet (1991) 1.88
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol (2007) 1.87
Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology (2000) 1.84
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet (1993) 1.82
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology (2003) 1.64
Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices. Aliment Pharmacol Ther (2009) 1.56
Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology (2003) 1.54
Schistosomal portal hypertension. J Am Coll Surg (2005) 1.42
Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology (1995) 1.21
A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol (1993) 1.11
Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol (1993) 1.10
Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology (1997) 1.08
A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology (1995) 1.07
[Evaluation of the methodological quality of randomized therapeutic trials]. Presse Med (1988) 0.99
Endoscopic treatments for portal hypertension. Semin Liver Dis (1999) 0.92
Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology (2009) 0.92
Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. Gastroenterology (1990) 0.89
Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology (1986) 0.88
Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding. J Coll Physicians Surg Pak (2009) 0.81
Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. Gastroenterology (1993) 0.79
Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study. Gut (1996) 0.79
Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy. J Hepatol (1994) 0.79
Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? J Gastroenterol Hepatol (2006) 0.79
[Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage]. Nihon Shokakibyo Gakkai Zasshi (1991) 0.79
Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. Acta Chir Scand (1990) 0.78
Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol (1989) 0.78
Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding. Gastrointest Endosc (2009) 0.77
Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study. J Gastroenterol Hepatol (1993) 0.77
Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating the effect of adjuvant propranolol therapy. J Egypt Soc Parasitol (2005) 0.76
Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study. J Clin Gastroenterol (1990) 0.76
Failure of combined efforts: propranolol and sclerotherapy do not add up to the prevention of variceal bleeding. J Hepatol (1993) 0.76
[Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging]. Rev Esp Enferm Dig (1994) 0.76
Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology (1992) 0.76
Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med (2014) 4.70
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology (2007) 3.75
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology (2004) 3.04
A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology (2005) 2.38
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology (2002) 2.06
Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol (2010) 1.94
Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive. Hepatology (2012) 1.94
Positioning trocars for performing sleeve gastrectomy. Points of controversy. Obes Surg (2015) 1.90
Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Res (2008) 1.81
Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol (2002) 1.81
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol (2011) 1.79
Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology (2013) 1.64
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int (2008) 1.62
Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem (2007) 1.57
Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology (2002) 1.55
Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med (2003) 1.55
The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia (2008) 1.55
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. J Rheumatol (2006) 1.53
Covered self-expandable biliary stents for the treatment of bleeding after ERCP. Gastrointest Endosc (2013) 1.47
Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol (2003) 1.47
Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet (2002) 1.44
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine (2007) 1.44
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. J Rheumatol (2013) 1.42
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine (2011) 1.41
Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology (2003) 1.39
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol (2002) 1.32
Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol (2008) 1.21
A semi-Markov model based on generalized Weibull distribution with an illustration for HIV disease. Biom J (2005) 1.19
Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis (2012) 1.18
Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol (2003) 1.18
Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol (2009) 1.16
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials. Lung Cancer (2006) 1.12
Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10
Laparoscopic totally extraperitoneal inguinal hernia repair: twenty-seven serious complications after 4565 consecutive operations. Rev Col Bras Cir (2013) 1.10
Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin Chem (2013) 1.09
Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication. J Hepatol (2012) 1.05
Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol (2011) 1.02
Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clin J Am Soc Nephrol (2013) 1.02
Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol (2013) 1.02
Treatment of chronic knee synovitis with arthroscopic synovectomy: longterm results. J Rheumatol (2002) 1.01
Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists. J Rheumatol (2004) 1.00
Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders. PLoS One (2009) 0.98
SPATCLUS: an R package for arbitrarily shaped multiple spatial cluster detection for case event data. Comput Methods Programs Biomed (2006) 0.98
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int (2009) 0.97
Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay. J Immunol Methods (2006) 0.96
Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl (2006) 0.96
New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol (2004) 0.95
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology (2014) 0.95
Laparoscopic Roux-en-Y gastric bypass with the absorbable bidirectional monofilament barbed suture Stratafix®: the hand-sewn technique. Obes Surg (2015) 0.94
Effect of catheter ablation for isolated paroxysmal atrial fibrillation on longitudinal and circumferential left ventricular systolic function. Am J Cardiol (2008) 0.94
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J Hepatol (2006) 0.94
Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study. Transpl Int (2009) 0.93
Ventilatory response and peak circulatory power: new functional markers of response after cardiac resynchronization therapy. Arch Cardiovasc Dis (2010) 0.92
[Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices]. Gastroenterol Clin Biol (2005) 0.92
Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis. Br J Haematol (2012) 0.92
Vascular involvement of the liver in Turner's syndrome. Hepatology (2004) 0.91
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain (2009) 0.90
Gastric bypass with unknown intestinal malrotation: Required attitude. Int J Surg Case Rep (2013) 0.90
Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C. BMC Gastroenterol (2011) 0.90
Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension. Hepatol Int (2008) 0.90
Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol (2008) 0.89
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol (2009) 0.89
A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. Hepatology (2003) 0.89
Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci (2007) 0.89
Influence of sex on disease severity in patients with rheumatoid arthritis. J Rheumatol (2005) 0.89
Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. Am J Hypertens (2011) 0.88
Isolation, characterization, and differentiation to hepatocyte-like cells of nonparenchymal epithelial cells from adult human liver. Stem Cells (2007) 0.88
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Liver Int (2006) 0.87
Psychometric validation of the French version of the quality of life in epilepsy inventory (QOLIE-31): comparison with a generic health-related quality of life questionnaire. Epileptic Disord (2004) 0.87
Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4alpha isoforms. Hepatology (2007) 0.87
Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis. Drugs (2013) 0.87
Optimization and robustness of blood tests for liver fibrosis and cirrhosis. Clin Biochem (2010) 0.87
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease. Liver Int (2010) 0.87
Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur J Gastroenterol Hepatol (2008) 0.86
Shape self-regulation in early lung morphogenesis. PLoS One (2012) 0.86
Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis. Cancer Med (2014) 0.85
Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Ann Hepatol (2012) 0.85
Laparoscopic entry techniques in obese patient: veress needle, direct trocar insertion or open entry technique? Obes Surg (2014) 0.84
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer. J Thorac Oncol (2008) 0.83
Comparison of hepatic-like cell production from human embryonic stem cells and adult liver progenitor cells: CAR transduction activates a battery of detoxification genes. Stem Cell Rev (2011) 0.83
Global sequencing approach for characterizing the molecular background of hereditary iron disorders. Clin Chem (2007) 0.83
Cost of lung cancer: a methodological review. Pharmacoeconomics (2006) 0.83
Impact of tobacco and alcohol consumption in patients registered on waiting list on early morbidity following liver transplantation. Clin Res Hepatol Gastroenterol (2013) 0.82
Evaluation of Baveno recommendations for grading esophageal varices. J Hepatol (2003) 0.82
Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. Ann Hepatol (2004) 0.82
Response to cardiac resynchronization therapy: the muscular metabolic pathway. Cardiol Res Pract (2010) 0.82